What is the most recent earnings date for HOTH stock?
HOTH THERAPEUTICS INC (HOTH) last reported earnings on 3/27/2026.
NASDAQ:HOTH • US44148G2049
Past quarterly earnings results for HOTH THERAPEUTICS INC (HOTH), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -0.16 | -0.10 | -56.86% | 50.00% | - | - | ||
| Q3 2025 | -0.30 | -0.10 | -194.12% | 3.23% | - | - | ||
| Q2 2025 | -0.17 | -0.14 | -19.05% | 29.17% | - | - | ||
| Q1 2025 | -0.27 | -0.27 | -1.81% | 41.30% | - | - | ||
| Q4 2024 | -0.32 | -0.38 | 15.21% | - | - | - | ||
| Q3 2024 | -0.31 | -0.35 | 10.61% | 48.33% | - | - | ||
| Q2 2024 | -0.24 | -0.44 | 45.28% | 57.89% | - | - | ||
| Q1 2024 | -0.46 | -0.44 | -4.88% | 47.73% | - | - | ||
| Q4 2023 | -0.32 | -0.52 | 38.49% | 88.81% | - | - | ||
| Q3 2023 | -0.60 | -0.74 | 18.86% | 70.73% | - | - | ||
| Q2 2023 | -0.57 | -1.18 | 51.83% | 74.67% | - | - | ||
| Q1 2023 | -0.88 | -0.88 | 0.26% | 68.00% | - | - | ||
| Q4 2022 | -2.86 | -2.34 | -22.44% | 18.29% | - | - | ||
| Q3 2022 | -2.05 | -2.44 | 16.08% | 41.43% | - | - | ||
| Q2 2022 | -2.25 | -2.42 | 7.12% | 35.71% | - | - | ||
| Q1 2022 | -2.75 | -3.57 | 22.97% | 54.17% | - | - | ||
| Q4 2021 | -3.50 | -3.19 | -9.80% | -250.00% | - | - | ||
| Q3 2021 | -3.50 | -3.44 | -1.67% | 12.50% | - | - | ||
| Q2 2021 | -3.50 | -4.34 | 19.26% | 30.00% | - | - | ||
| Q1 2021 | -6.00 | -2.55 | -135.29% | -33.33% | - | - | ||
| Q4 2020 | -1.00 | -2.55 | 60.78% | - | - | - | ||
| Q3 2020 | -4.00 | -3.44 | -16.19% | - | - | - | ||
| Q2 2020 | -5.00 | -3.83 | -30.72% | - | - | - | ||
| Q1 2020 | -4.50 | -4.25 | -5.88% | - | - | - |
Notes
HOTH THERAPEUTICS INC (HOTH) last reported earnings on 3/27/2026.
HOTH THERAPEUTICS INC (HOTH) missed EPS estimates and missed revenue estimates in the most recent quarter.
In the last 4 quarters, HOTH THERAPEUTICS INC (HOTH) has beaten EPS estimates in 0 out of 4 releases.